Updated Guidelines, Consensus and Evidence-Based Reports in Breast Cancer – Now Published! (Curr Oncol 2015;22(Suppl 1)) Multimed Inc. is pleased to

 
CO-NEWSLETTER-LOGO withdate
OE-asco-static
***
CO-COVER-ISSUE

Updated Guidelines, Consensus and Evidence-Based Reports in Breast Cancer – Now Published!

(Curr Oncol 2015;22(Suppl 1))

Multimed Inc. is pleased to announce that Current Oncology has published a supplement dedicated to breast cancer, edited by Dr. Maureen Trudeau from the Sunnybrook Health Sciences Centre in Toronto, Ontario.

The supplement contains up to date and evidence-based guidelines and consensus statements in breast cancer, including those recently completed by Cancer Care Ontario’s Program in Evidence Based Care. There are also reviews covering outcome of patients with pregnancy during or after breast cancer, targeted therapy in HER2-positive metastatic breast cancer, and systemic treatment in HER2-neagative advanced breast cancer.

To view the full-text articles from this special issue, visit http://www.current-oncology.com/index.php/oncology/issue/view/92/showToc.

Have an idea or suggestion for a special issue that you believe is of importance to the Canadian and/or International oncology community? Please email current_oncology@multi-med.com.

logo70

Multimed Inc.
Publisher of Current Oncology
www.multi-med.com

***
CO Twitter Banner Ad
***
InPress-CON
***
LookingAhead-CON

Upcoming in Current Oncology

The future table of contents for Current Oncology, Volume 22, Number 3 (June 2015) is now available. For the most up-to-date listing of scheduled papers, please visit the following link:
http://www.current-oncology.com/index.php/oncology/about/futureTOC

***
EditorSpotlight
TY Media Picture

Tallal Younis, MBBCh, FRCP (UK)
Editor of our Medical Oncology Section (since June 2013)

Dr. Younis received his medical degree from Cairo University in 1992. He completed an internal medicine residency in 2001 at Columbia University, New York, and a Medical Oncology Fellowship in 2003 at the Roswell Park Cancer Institute, State University of New York at Buffalo.

Dr. Younis is currently a medical oncologist at the Queen Elizabeth II Health Sciences Centre in Halifax, with a clinical practice focused on breast cancer. He is a co-chair of the Nova Scotia provincial breast site team, and a member the Pan Canadian Oncology Drug Review – Expert Review Committee (pCODR – ERC) as well as both the clinical and research advisory groups of the Canadian Partnership Against Cancer (CPAC).

Dr. Younis is an associate professor of Medicine, and a clinical research scholar, at Dalhousie University. His research interests involve health economics and health services research in breast cancer. He has been an editor for the medical oncology section in Current Oncology since 2013.

***
HaveYouHeard-CON

Current Oncology in the News!

The article titled “A population-based study of ethnicity and breast cancer stage at diagnosis in Ontario”, by Dr. O.M. Ginsburg et al., has received much media coverage since publication in the April 2015 issue of Current Oncology. The study reports that South Asian women are more likely to be diagnosed with later stage breast cancer compared to the general population, while Chinese women are more likely to be diagnosed with early stage cancer.

Click here to read interview with Dr. Ginsburg and report by CTV News
Click here to read interview with Dr. Ginsburg and report by Global News


NewDesign

New Look For Current Oncology

We are pleased to announce that we have completed a redesign of the journal’s article format, which will launch with the June 2015 issue. Highlights of the new design include:

• Easy access to citation information for articles
• Abstract & corresponding author prominent on 1st page
• Reduced font - allowing for publication of more articles in both print & online format
• Introduction of shading for easier reading and interpretation of tables

We hope our readers enjoy Current Oncology’s new look!


Lilly Oncology on Canvas Canada Art Competition – Winners Announced

Lilly Canada is proud to announce Anne Louise Davies of Courtenay, B.C. as the Overall Best of Exhibition Winner for her entry, In the Dance, in the inaugural Lilly Oncology on Canvas Canada art competition.

Lilly Oncology on Canvas Canada (LOCC) was created to help those affected by cancer cope with the emotional and physical effects of this disease, through the artistic representation of their cancer journey. Contest entries will be featured in healthcare centres across the country later this year.

• Overall Best of Exhibition Winners*:
o 1st Prize Winner: Anne Louise Davies, In the Dance, B.C. $2000 donation to YANA (You Are Not Alone)
o 2nd Prize Winner: Maureen Schwanke, Walking to the Future, MB, $1000 donation to Hamiota Cancer Care Program
o 3rd Prize Winner (Tie):
Lyn Howlett, Chemo Roller Coaster, ON, $500 donation to Art for Cancer Foundation
Anonymous, Colours of Strength, ON, $500 donation to Ottawa Hospital Foundation

• Best of Participant Category Winners, each awarded a $250 donation:
o Person diagnosed with cancer: Anne Louise Davies, In the Dance, B.C. donation to YANA (You Are Not Alone)
o Family member or loved one: Anonymous, The Final Journey, SK, donation to Prostate Cancer Canada

• Best of Participant Category Winners in Each Medium, each awarded a $250 donation:
o Best Painting: Anne Louise Davies, In the Dance, B.C. donation to YANA (You Are Not Alone)
o Best Mixed Media (Tie):
Anonymous, Colours of Strength, ON, donation to Ottawa Hospital Foundation
Lyn Howlett, Chemo Roller Coaster, ON, donation to Art for Cancer Foundation

*Please note that several of our winners have chosen to remain anonymous. As such, Lilly has not included their names in the winners’ list.

Starting with the April issue, Current Oncology covers will now feature art from the Canadian competition. A big thank you to Current Oncology for its support!

LOCC is presented by Lilly Canada’s Oncology team, the Canadian Association of Psychosocial Oncology (CAPO) and the Canadian Cancer Survivors Network (CCSN).

***
ReadersChoice-COn

Have you had the chance to view these Current Oncology “Most-Read” articles?

Most Read Articles in PubMed Central (March 2015)

Management of arthralgias associated with aromatase inhibitor therapy
Thorne C.
Curr Oncol. 2007 Dec;14 Suppl 1:S11-9

Prophylaxis and management of acute radiation-induced skin reactions: a systematic review of the literature
Salvo N, Barnes E, van Draanen J, Stacey E, Mitera G, Breen D, Giotis A, Czarnota G, Pang J, De Angelis C.
Curr Oncol. 2010 Aug;17(4):94-112

Legalizing euthanasia or assisted suicide: the illusion of safeguards and controls
Pereira J.
Curr Oncol. 2011 Apr;18(2):e38-45


Most Read Recently* Published Articles at www.current-oncology.com

Patients' perceptions of gene expression profiling in breast cancer treatment decisions
Bombard Y, Rozmovits L, Trudeau ME, Leighl NB, Deal K, Marshall DA
Curr Oncol. 2014 Apr;21(2):e203-11. doi: 10.3747/co.21.1524

Evidence-based guidance on venous thromboembolism in patients with solid tumours
Shea-Budgell MA, Wu CM, Easaw JC.
Curr Oncol. 2014 Jun;21(3):e504-14. doi: 10.3747/co.21.1938

The role of interventional radiology in the management of hepatocellular carcinoma
Molla N, AlMenieir N, Simoneau E, Aljiffry M, Valenti D, Metrakos P, Boucher LM, Hassanain M.
Curr Oncol. 2014 Jun;21(3):e480-92. doi: 10.3747/co.21.1829

*Published within past 12 months

***
CO-NEWS-MEETINGALERT

Join us for the Best of ASCO – Toronto, Montreal, Vancouver!

OncologyEducation.com’s Best of ASCO® Conference is a program licensed by the American Society of Clinical Oncology. Held June 11th, 2015 in Montreal, June 12th in Toronto and July 10th in Vancouver. The focus of this event will be to provide medical oncologists and other healthcare practitioners in Canada with a summary of the most significant treatment advances presented at the ASCO 2015 Annual Meeting, with presentations focused on several key disease sites.

Meeting Objectives:
1. To summarize the most significant treatment advances presented at ASCO 2015;
2. To review the current standard of care for key malignancies; and
3. To discuss the current controversies in the management of specific cancers.

Target Audience:
Medical oncologists, pharmacists, nurses, and other oncology healthcare professionals.

Other Information:
This meeting has been approved by the American Society of Clinical Oncology. Best of ASCO® and any related logos are trademarks of the American Society of Clinical Oncology®. All continuing medical education credits are transferable between the USA and Canada.

Visit our website for more details!


CAPhO Conference 2015

CAPhO Conference 2015 (CAPhO 2015), presented by the Canadian Association of Pharmacy in Oncology (CAPhO), will take place May 21-24, 2015 at the Delta St. John’s Hotel and Conference Centre in St. John’s, Newfoundland.

The theme of CAPhO 2015 is Change, Challenge and Opportunity.

Change: Personalized medicine with complex targeted therapies, innovative delivery models, and patient engagement have changed the way cancer is treated.

Challenge: Significant advances in the treatment of cancer come at a turbulent time, as the population is aging, the incidence of cancer is on the rise and the costs of providing treatment are continually escalating.

Opportunity: With change and challenge comes opportunity, particularly for oncology pharmacists. CAPhO 2015 will cover a wide range of topics including recent developments in supportive care, chemotherapy delivery and safety, emerging models of cancer care, and updates in cancer management. The Conference will consist of a combination of plenary sessions, panel presentations, concurrent sessions, interactive workshops and industry symposia. We hope that you will be part of this engaging event to learn innovative strategies, network with your peers and continue with your commitment to improving oncology pharmacy.

For more information about CAPhO 2015 and to sign up for the E-Newsletter, visit www.capho.org/conference or contact conference@capho.org.

***
300 x 80px-01
***
QuickLinks-CON
***

Contact Us

Email-CON
 
Address-CON
 
Phone-CON
 
Web-CON
twitter
1px